Oklahoma Administrative Code
Title 475 - Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
Chapter 30 - Labeling Requirements
Section 475:30-1-5 - Dispensing of narcotic drugs during scientific research
Current through Vol. 41, No. 13, March 15, 2024
(a) The administering or dispensing directly (but not prescribing) of narcotic drugs in any schedule to a narcotic drug dependent person for the purpose of continuing his/her dependence upon such drugs in the course of conducting an authorized clinical scientific research in the development of a narcotic addict rehabilitation program shall be deemed to be within the meaning of the term "in the course of his/her professional practice or research"; PROVIDED that approval is obtained prior to the initiation of such a program by submission of a protocol submitted to the OBN and the State of Oklahoma Department of Mental Health and Substance Abuse Services. It will be reviewed by the State of Oklahoma Department of Mental Health and Substance Abuse Services for scientific merit and qualifications and by the OBN for controlled dangerous substance requirements as provided by the Uniform Controlled Dangerous Substances Act and this Chapter.
(b) Nothing in this Title shall prohibit a physician who is not specifically registered to conduct a narcotic treatment program from administering (but not prescribing) narcotic drugs to a person for the purpose of relieving acute withdrawal symptoms, when necessary, while arrangements are being made for referral for treatment. Not more than one (1) day's medication may be administered to the person or for the person's use at one time. Such emergency treatment may be carried out for not more than three (3) days and may not be renewed or extended.
